SPT16 inhibitors are a class of chemical compounds that target a specific protein known as SPT16 (Suppressor of Ty 16), which plays a crucial role in chromatin remodeling and gene transcription processes within cells. These inhibitors are designed to modulate the activity of SPT16 by binding to it and interfering with its function. SPT16 is a subunit of the FACT (Facilitates Chromatin Transcription) complex, which is responsible for nucleosome disassembly and facilitating the passage of RNA polymerase II during transcription. This complex is essential for the regulation of gene expression in eukaryotic cells. SPT16 inhibitors, therefore, have the ability to impact gene transcription and chromatin structure, making them valuable tools for studying the fundamental mechanisms of gene regulation.
The mechanism of action of SPT16 inhibitors typically involves disrupting the interactions between SPT16 and its binding partners or interfering with its enzymatic activity. By doing so, these compounds can lead to alterations in chromatin structure and gene expression patterns, ultimately influencing various cellular processes. Researchers have been investigating SPT16 inhibitors as a means to gain insights into the molecular mechanisms underlying gene regulation and to explore their role in basic research and discovery. Understanding the specific ways in which SPT16 inhibitors impact gene transcription and chromatin dynamics can provide valuable insights into cellular biology and may have implications in the development of novel approaches for manipulating gene expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound can induce DNA demethylation, potentially leading to changes in gene expression, including downregulation of SPT16. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
This antibiotic intercalates into DNA and inhibits RNA polymerase, potentially reducing SPT16 mRNA synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
By inhibiting protein synthesis, this compound could lead to a decrease in SPT16 levels over time. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
As an mTOR inhibitor, rapamycin can downregulate protein synthesis, potentially impacting SPT16 levels. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
This antimetabolite can inhibit RNA synthesis, possibly leading to decreased SPT16 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
This topoisomerase I inhibitor can induce DNA damage, potentially influencing SPT16 expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
As an antifolate, this compound can disrupt DNA and RNA synthesis, which may lead to reduced SPT16 expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
This ribonucleotide reductase inhibitor can disrupt DNA synthesis, potentially affecting SPT16 levels. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Similar to 5-Azacytidine, this compound induces DNA demethylation, potentially altering SPT16 expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
This compound forms DNA adducts, leading to DNA damage and potentially impacting SPT16 expression. | ||||||